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data for future epidemiological research because of the substantial overlap in data requirements. 
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Introduction 
Radiation oncologists are medical specialists who 
manage cancer patients and employ radiation therapy 
as their main treatment modality. It is estimated that 
50% of the patients who are identified in annual can-
cer incidence records will receive radiation therapy at 
some time after their diagnosis; indeed, service plan-
ning is often based on this estimate (Delaney et al. 
2005). 
The speed of infiltration of information technologies 
into radiation oncology has been astounding. So rapid 
has it been been that while most departments are 
equipped with an advanced Oncology Information Sys-
tem (OIS), few are fully aware of the improvements 
that can be achieved by a wider implementation that 
includes the radiation oncologist's work flow. Coupled 
with this under-appreciation is the dearth of experi-
enced implementation services, and the reticence of 
oncology administrators to provide the substantial re-
sources required to achieve meaningful implementation.  
This paper describes the potential role that radia-
tion oncologists can play in ensuring that data for epi-
demiological research is accurate and complete. The 
impact of the OIS in changing work flow will be dis-
cussed in another paper. 
Discussion 
Current data collection paradigms 
There is an unfortunate dichotomy in the handling and 
status of current oncological data. In many centres a 
single source of data (interaction with a patient) re-
sults in dual systems of data flow. This dichotomy re-
sults from historical methods of data collection in the 
paper era which persist into the electronic era. 
The first data flow system consists of 'normal' clini-
cal data which is transmitted within a free text format, 
whether stored on paper or electronically. Similar to 
all such documentation, this data format is highly ex-
plicit, highly variable, largely immutable, difficult to 
analyse, poorly structured and unsystematised. The 
resultant data repository is prized as the clinical record 
but of little additional use. 
The second data flow system consists of 'research' 
data which is based on the same clinical source but 
transmitted within a quantised format; that is, data 
that is classified in accordance with strictly defined 
categories, such as the National Cancer Institute's 
Common Toxicity Criteria. This format is highly im-
plicit, invariable, highly mutable, easy to analyse, 
highly structured, systematised and often validated. 
To collect and collate this type of oncological data for 
research, many departments developed substantial 
data 'management' bureaucracies. These systems ex-
ist in parallel with and largely duplicate or parasitise 
the paper-based process of routine clinical data collec-
tion. 
While routine data is usually recorded by clinicians 
and other staff in a text format, when specialised data 
collection is required, an additional process follows 
which requires that the identical data be quantised 
according to well recognised and validated categories 
(e.g., ICD-0 diagnostic codes, AJCC/UICC staging 
codes, NCI CTC 99 side effect criteria, RTOG/EORTC 
acute toxicity categories, LENT/SOMA scoring). Many 
of these categories are now also used in routine prac-
tice.  
While the source of data is identical (the patient) 
and the content is identical, the 'research' collection is 
more structured than the 'normal' clinical data. Fre-
quently these categorisations are scored by clinicians 
and then transferred to an electronic database by data 
managers within the bureaucracy. Moreover, it is not 
unknown for data managers to attempt to extract the 
quantised data from routine notes. Thus a single clini-
cal interaction results in two essentially contextually 
identical but differently structured entries. 
Difficulties in the recording of data within the two 
systems can be seen when a clinician might, for ex-
ample, report in the clinical notes that a patient has 
‘mild to moderate skin reaction’. However, when en-
tering this as trial data, the entry systems will require 
that the assessment of this patient's skin (as a quan-
tised RTOG Acute Skin Reaction) be ‘1’ (meaning faint 
erythema, a mild reaction) or ‘2’ (meaning bright ery-
thema, dry desquamation; a moderate reaction), as 
there is no ‘1.5 — mild to moderate’ choice. 
At sites where there are medical staff with some IT 
experience and ability, the tendency has been for 
them to build their own individualised but parallel elec-
tronic data repositories. These microcosms mirror the 
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functionality of the data bureaucracy by being sepa-
rate from the routine clinical system, often addressing 
an area of personal interest. These data repositories 
rarely influence normal data recording, or feed back to 
correct errors in the clinical record. (It is not unknown 
for departments to have all three varieties — routine 
clinical, data manager-based and personal data reposi-
tories!). 
Unfortunately, quality assurance is usually not a 
prominent feature of any of these systems. In the first 
case, routine clinical data is rarely reviewed or 
changed; indeed, in some circumstances, it is consid-
ered an offence to alter data. In the second case, the 
degree of knowledge required to accurately assure 
data resides within medical staff who are largely pe-
ripheral to the operations of the bureaucracy. In the 
third case, the medical staff member frequently as-
sumes that once the data is collected it is accurate 
because it represents a personal endeavour. The 
workload to compare multiple data sources with in-
compatible formats is largely manual and extremely 
difficult. 
In 'research' cases, data collection is divorced from 
the normal stream of clinical activity and the situations 
where data are usually collected. Previous attempts to 
quality assure these data collections have found errors 
of over 20% (Evans et al. 1998; Hobson, Khemani & 
Singh, 2005; McCulloch, Ward & Tekkis, 2003; Warsi, 
White & McCulloch, 2002). These rates are unaccept-
able in data used for epidemiological purposes. 
Surprisingly, modern oncology is very fortunate be-
cause of the widespread tendency to categorise most 
of the oncological parameters associated with patients. 
This tendency stems from the utility and long tradition 
of statistical analysis in determining what strategies 
are useful in the management of the cancer patient.  
Oncologists therefore are aware of the importance 
of data and the formats used in research, but gener-
ally have been unable to develop and implement co-
herent strategies for data collection and verification in 
this format within the normal workflow.  
The result is the aforementioned circumstance 
which conspires to duplicate and divide clinical data. 
From the data viewpoint, this may render the majority 
of data of little use for epidemiological research. From 
the clinical viewpoint, this may compromise the quality 
of patient care because the clinician might not have 
access to the latest and best data. 
Future data collection paradigms 
Data collection is a necessary process within each and 
every radiation oncology department. Radiation use is 
accompanied by a lengthy and detailed audit, with all 
Australian and New Zealand radiation oncology de-
partments being required by legislation to collect and 
retain the details of the specifications and delivery of 
radiation for many years up to and after the death of 
the patient. The National Radiation Laboratory of New 
Zealand requires that a department should keep a 
computerised clinical database. Item 8.2.3 states:  
A suitable computerised cancer registry should 
be maintained that contains data on radiotherapy 
treatments and outcomes of at least the most 
common types of cancer. Treatment data should 
include details of the radiotherapy (target dose, 
fractionation system, etc) together with other 
treatment modalities used in combination. Out-
come data should include tumour response, 
morbidity, mortality, and recurrence. (New Zea-
land National Radiation Laboratory 1992). 
Similar regulatory requirements offer the prospect 
of routine data collection that might be provided for 
epidemiological research. 
The recent availability of the modern OIS has 
promised, but not fulfilled, new opportunities for epi-
demiological research where the implementation of 
new systems within radiation oncology departments 
based on modern paradigms of data manipulation, 
data storage and retrieval will result in better vali-
dated and newer forms of data being available 
(Chamorro 2001). 
The construct that provides the most favourable 
conditions for data acquisition for epidemiological re-
search is one where all routine data collection within a 
department is based on the quantised data paradigm. 
That is, all data is regarded as and collected as if it 
were research data. This constitutes a reversal of most 
features within current data flows. To achieve this 
status, departments should assess software purchases 
intended for routine clinical use to discover whether it 
contains a repository with categorised data in a quan-
tised format consistent with the type already acquired 
by data managers. Such a repository should cover all 
required fields and be expandable to include all de-
sired fields within the areas of Record & Verify, Sched-
ule, Document Repository, Clinical Assessments and 
Disease & Treatment outcome measures. 
The modern oncology department will require that 
any newly purchased OIS will also be able to under-
take other functionality including scheduling and bill-
ing, as well as integrate into the hospital's overall IT 
strategy. While the functions that enable the day-to-
day running of the department are important, they are 
not the raison d'être or the prime benefit of OIS. 
These systems improve efficiency by virtue of their 
ability to integrate data, improve workflow and in-
crease safety within the oncology context. Rather than 
applying resources to force radiation staff to use a 
generic Hospital Information System (HIS) and lose 
efficiency in the oncology department, effort should be 
expended in establishing data flow between the OIS 
and HIS. 
The implementation of this new construct requires 
reorganisation based on the equally new and impor-
tant concept of data ownership. The primary aims of 
any repository ultimately used for research should be 
data coverage (all items completed) and data integrity 
(all data makes sense). To achieve this in a normal 
clinical workflow requires the inclusion of the concept 
of ownership. This is a specifically assigned responsi-
bility for data creation, collection and integrity within 
an organisation, rather than an emotional attachment 
to the data collection process, or a legal concept.  
Once clinical data is discovered (such as the diag-
nosis), electronic data should be immediately entered 
in a quantised format by its owner. This data is then 
immediately available for use within the normal clinical 
process, and for automated quality reporting to de-
termine whether it is complete and whether it is inter-
nally consistent. For example, it should be possible to 
use a database report at the end of a clinic to match 
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the schedule list of follow-up visits with entries detail-
ing patient follow-up assessments to look for entries 
that have not been undertaken or are incomplete. The 
data owner can then attend to the correction of the 
identified entries.  
Of course the determination and assignment of 
data to particular groups can be difficult, as this ex-
plicit paradigm is not active in many departments and 
may cut across an individual's view of their profes-
sional standing and function within a system. The 
presence of a system of data managers tends to rein-
force the view that their data is somehow different to 
the normal clinical data. The delegation of data collec-
tion to data managers was a pragmatic decision that 
occurred when there were no options for electronic 
records.  This is not the case now and so the decision 
to delegate needs to be reassessed. The new OIS 
permits a department to reverse this delegation and 
redeploy data managers away from data collection and 
data entry towards ensuring quality and coverage, and 
undertaking analysis. 
Nevertheless, the concept of data responsibility 
should be associated with frequent quality assurance 
of the assigned dataset, looking specifically at comple-
tion rate and data coherence, and substituting this 
data collection for normal clinical recording. Obviously, 
it would be a major undertaking to attempt to quan-
tise all features of the clinical record, however, at-
tempts to isolate areas where quantised data already 
exist and cover a major portion of an area should have 
early success. Treatment effects is such an area, 
where symptomatology is well described (e.g. NCI 
Common Toxicity Criteria). 
While the proposed changes are substantial, some 
of the currently available OISs already possess this 
degree of functionality. The size of these software sys-
tems is daunting, however, and to expect busy over-
worked clinical radiation oncologists to undertake the 
process of discovery, procedural design and imple-
mentation within their work space is wishful thinking. 
Unfortunately, other professional groups are equally 
unlikely to be successful in undertaking this implemen-
tation. Professional implementation services for these 
systems are difficult to find, as implementation re-
quires a high degree of knowledge about the radiation 
oncologist's work patterns and data use, the software 
design and its operational features. The result of pur-
chasing implementation services should be a coherent 
system designed to deliver data of research quality 
while achieving similar clinical outcomes, and, it is 
hoped, with less effort. Implementation costs are built 
into other software projects (e.g., PACS introduction), 
however there has been no similar process considered 
in radiation oncology. Estimating the cost of imple-
mentation is difficult, but personal communications 
suggest that implementation costs are similar to or in 
excess of the purchase cost of the software. 
Some of the methodologies required to reconcile 
and integrate these systems into current practice will 
be the subject of a later article. 
There are distinct advantages in the linking of 
these patterns of prospective data collection within a 
computerised clinical system if the methodologies of 
collection are synchronised with the desire to reuse 
the data to answer research questions. Other benefits 
accrue from this approach. There have already been 
calls for retrospective practice reviews of patient out-
comes to be subject to the same ethics committee ap-
proval process as prospective trials (Lertsithichai 
2005). Where the quantising and storage of clinical 
data uses nationally approved and internationally rec-
ognised codes in a process of continuous prospective 
data collection to replace the usual text-based clinical 
record, there are no requirements for approval by eth-
ics and professional bodies, or to ask a patient's con-
sent to keep a record, or indeed, to even inform them 
of the record.  
This approach is based on the fact that the genera-
tion of a clinical record is necessary in all medical 
situations; however, the format of such a record is not 
mandated by legislation. When reporting on the infor-
mation within the database, confidentiality can be 
maintained by use of the unique database number as-
signed to each patient, which has no relationship to 
the Medical Record Number, and by the ability to in-
clude relevant patients in a report without actually 
opening the patient's record. In a well designed sys-
tem, assiduous, frequent and early quality assurance 
of the entered data will negate the need to individually 
review charts.  
Data security and storage can be integrated within 
a hospital's IT initiatives. Although the OIS is a sepa-
rate system, its data can be freely exchanged with the 
HIS or any other database through common formats 
(e.g., NSW Department of Health Radiotherapy Infor-
mation Strategy where waiting time data is reported 
directly from the OIS, and where a minimum dataset 
of diagnostic and therapy data is reported to the NSW 
Cancer Registry) so that the process engineering 
benefiting the oncology department is used while the 
requirement for data accumulation within the HIS is 
also met. The resultant system does not require the 
generation of paper forms except as mandated by 
regulation. 
Conclusion 
There is a surfeit of data collected within normal clini-
cal radiation oncology using outdated text-based 
methods that result in repositories of largely unusable 
data. Implementation of a modern electronic OIS that 
stores data in quantised formats (e.g., NCI Common 
Toxicity Criteria) will enable routine clinical data to 
achieve a status similar to current research data.  
The paradigm of data ownership with its attendant 
quality assurance implications can be used to con-
struct a system which is able to ensure data coverage 
and integrity. Transfer of this routine data can provide 
epidemiological agencies with oncological data with a 
high degree of clinical assurance. 
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